In vitro studies of inhibitory activity of plant extracts and cow urine on mycelial growth of stem rot, Sclerotimoryzae of rice

Soil borne phytopathogen Sclerotiumoryzae significantly affect rice production. To reduce load of chemical pesticides, antifungal activity of plant extracts and cow urine against mycelial growth of S.oryzaewere tested using poisoned food technique under in vitro condition. Plant extracts of 2.5%, 5.0%, 7.5% and 10% concentration was prepared from Allium cepa, Azadirachtaindica, A. sativum, Ricinuscommunisand Syzygiumcumini. Inhibition of mycelial growth of S.oryzaewas recorded only in case of A. sativum and A. cepa while Azadirachtaindica, Ricinuscommunisand Syzygiumcumini did not show any inhibition of mycelial growth as compared to control. A.sativum plant extracts showed maximum inhibition of mycelia growth of 68.88% at concentration 10% followed by 32.96%, 22.96% and 18.88% at concentration 7.5%, 5.0% and 2.5% resepectively. 22.60%, 19.62%, 17.77% and 8.88% inhibition of mycelial growth as compared to control was recorded at 10%, 7.5%, 5.0% and 2.5% concentration of plant extracts of A.cepa. All the concentration of cow urine inhibited the mycelial growth of S. oryzae. Cow urine at the concentration 5, 7.5 and 10.0 per cent resulted in 100 per cent inhibition of mycelia growth of test pathogen as compared to control. Maximum inhibition of 98.14 per cent was observed at 2.5 per cent concentration followed by 1.25 per cent (63.7%) concentration. This study showed that A.sativum and A.cepa and cow urine possess antifungal activity under in vitro condition. It can also be tested for antifungal activity under in vivo condition

MeMLO: Mobility-Enabled Multi-Level Optimization Sensor Network

The paper presents a technique called as Mobility-enabled Multi Level Optimization (MeMLO) that addressing the existing problem of clustering in wireless sensor net-work (WSN). The technique enables selection of aggregator node based on multiple optimi-zation attribute which gives better decision capability to the clustering mechanism by choosing the best aggregator node. The outcome of the study shows MeMLO is highly capable of minimizing the halt time of mobile node that significantly lowers the transmit power of aggregator node. The simulation outcome shows negligible computational com-plexity, faster response time, and highly energy efficient for large scale WSN for longer simulation rounds as compared to conventional LEACH algorithm

Dynamic Scaling in Diluted Systems Phase Transitions: Deactivation trough Thermal Dilution

Activated scaling is confirmed to hold in transverse field induced phase transitions of randomly diluted Ising systems. Quantum Monte Carlo calculations have been made not just at the percolation threshold but well bellow and above it including the Griffiths-McCoy phase. A novel deactivation phenomena in the Griffiths-McCoy phase is observed using a thermal (in contrast to random) dilution of the system.Comment: 4 pages, 4 figures, RevTe

First steps on the resistance profiling of Kawisari coffee hybrid through cytological and gene expression analyses

info:eu-repo/semantics/publishedVersio

Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism

From the identification of HIV as the agent causing AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research over the past twenty-six years have been formidable. Currently, there are twenty-five anti-HIV compounds which have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), cell entry inhibitors or fusion inhibitors (FIs), co-receptor inhibitors (CRIs), and integrase inhibitors (INIs). Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. Formation of active or toxic metabolites will also have an impact on the pharmacological and toxicological outcomes. Therefore, it is widely recognized that metabolism studies of a new chemical entity need to be addressed early in the drug discovery process. This paper describes an overview of the metabolism of currently available anti-HIV drugs.Da identificação do HIV como o agente causador da AIDS, ao desenvolvimento de fármacos antirretrovirais eficazes, os avanços científicos na pesquisa sobre o HIV nos últimos vinte e seis anos foram marcantes. Atualmente, existem vinte e cinco fármacos anti-HIV formalmente aprovados pelo FDA para utilização clínica no tratamento da AIDS. Estes compostos são divididos em seis classes: inibidores nucleosídeos de transcriptase reversa (INTR), inibidores nucleotídeos de transcriptase reversa (INtTR), inibidores não-nucleosídeos de transcriptase reversa (INNTR), inibidores de protease (IP), inibidores da entrada celular ou inibidores de fusão (IF), inibidores de co-receptores (ICR) e inibidores de integrase (INI). O metabolismo consiste em um dos maiores determinantes do perfil farmacocinético de um fármaco. A formação de metabólitos ativos ou tóxicos terá impacto nas respostas farmacológicas ou toxicológicas do fármaco. Portanto, é amplamente reconhecido que estudos do metabolismo de uma nova entidade química devem ser realizados durante as fases iniciais do processo de desenvolvimento de fármacos. Este artigo descreve uma abordagem do metabolismo dos fármacos anti-HIV atualmente disponíveis na terapêutica

The Public Repository of Xenografts enables discovery and randomized phase II-like trials in mice

More than 90% of drugs with preclinical activity fail in human trials, largely due to insufficient efficacy. We hypothesized that adequately powered trials of patient-derived xenografts (PDX) in mice could efficiently define therapeutic activity across heterogeneous tumors. To address this hypothesis, we established a large, publicly available repository of well-characterized leukemia and lymphoma PDXs that undergo orthotopic engraftment, called the Public Repository of Xenografts (PRoXe). PRoXe includes all de-identified information relevant to the primary specimens and the PDXs derived from them. Using this repository, we demonstrate that large studies of acute leukemia PDXs that mimic human randomized clinical trials can characterize drug efficacy and generate transcriptional, functional, and proteomic biomarkers in both treatment-naive and relapsed/refractory disease

On the mechanisms governing gas penetration into a tokamak plasma during a massive gas injection

A new 1D radial fluid code, IMAGINE, is used to simulate the penetration of gas into a tokamak plasma during a massive gas injection (MGI). The main result is that the gas is in general strongly braked as it reaches the plasma, due to mechanisms related to charge exchange and (to a smaller extent) recombination. As a result, only a fraction of the gas penetrates into the plasma. Also, a shock wave is created in the gas which propagates away from the plasma, braking and compressing the incoming gas. Simulation results are quantitatively consistent, at least in terms of orders of magnitude, with experimental data for a D 2 MGI into a JET Ohmic plasma. Simulations of MGI into the background plasma surrounding a runaway electron beam show that if the background electron density is too high, the gas may not penetrate, suggesting a possible explanation for the recent results of Reux et al in JET (2015 Nucl. Fusion 55 093013)

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

We show the distribution of SARS-CoV-2 genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three available genomic nomenclature systems for SARS-CoV-2 to all sequence data from the WHO European Region available during the COVID-19 pandemic until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation. We provide a comparison of the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.Peer reviewe

Volume I. Introduction to DUNE

The preponderance of matter over antimatter in the early universe, the dynamics of the supernovae that produced the heavy elements necessary for life, and whether protons eventually decay—these mysteries at the forefront of particle physics and astrophysics are key to understanding the early evolution of our universe, its current state, and its eventual fate. The Deep Underground Neutrino Experiment (DUNE) is an international world-class experiment dedicated to addressing these questions as it searches for leptonic charge-parity symmetry violation, stands ready to capture supernova neutrino bursts, and seeks to observe nucleon decay as a signature of a grand unified theory underlying the standard model. The DUNE far detector technical design report (TDR) describes the DUNE physics program and the technical designs of the single- and dual-phase DUNE liquid argon TPC far detector modules. This TDR is intended to justify the technical choices for the far detector that flow down from the high-level physics goals through requirements at all levels of the Project. Volume I contains an executive summary that introduces the DUNE science program, the far detector and the strategy for its modular designs, and the organization and management of the Project. The remainder of Volume I provides more detail on the science program that drives the choice of detector technologies and on the technologies themselves. It also introduces the designs for the DUNE near detector and the DUNE computing model, for which DUNE is planning design reports. Volume II of this TDR describes DUNE\u27s physics program in detail. Volume III describes the technical coordination required for the far detector design, construction, installation, and integration, and its organizational structure. Volume IV describes the single-phase far detector technology. A planned Volume V will describe the dual-phase technology